Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder

Lignende værker

• A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
  af: Alvarez, Enric, et al.
  Udgivet: (2012)
• Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
  af: Chen, Grace, et al.
  Udgivet: (2013)
• Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  af: Alam, Mohammed Y., et al.
  Udgivet: (2014)
• A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD
  af: Mahableshwarkar, Atul R., et al.
  Udgivet: (2015)
• A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
  af: McIntyre, Roger S., et al.
  Udgivet: (2014)